Bioventus Inc. (BVS)
NASDAQ: BVS · Real-Time Price · USD
7.69
-0.04 (-0.52%)
Apr 25, 2025, 4:00 PM EDT - Market closed
Bioventus Stock Forecast
Stock Price Forecast
The 4 analysts with 12-month price forecasts for Bioventus stock have an average target of 15, with a low estimate of 13 and a high estimate of 17. The average target predicts an increase of 95.06% from the current stock price of 7.69.
Analyst Consensus: Strong Buy
* Price targets were last updated on Mar 17, 2025.
Analyst Ratings
The average analyst rating for Bioventus stock from 4 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '24 | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 3 | 3 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 3 | 3 | 3 | 4 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $15 | Strong Buy | Maintains | $15 | +95.06% | Mar 17, 2025 |
| JP Morgan | JP Morgan | Sell → Hold Upgrades $12 → $13 | Sell → Hold | Upgrades | $12 → $13 | +69.05% | Dec 17, 2024 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $12 → $15 | Strong Buy | Maintains | $12 → $15 | +95.06% | Nov 6, 2024 |
| Craig-Hallum | Craig-Hallum | Strong Buy Maintains $12 → $17 | Strong Buy | Maintains | $12 → $17 | +121.07% | Sep 27, 2024 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $8 → $12 | Strong Buy | Maintains | $8 → $12 | +56.05% | Aug 13, 2024 |
Financial Forecast
Revenue This Year
570.52M
from 573.28M
Decreased by -0.48%
Revenue Next Year
605.29M
from 570.52M
Increased by 6.09%
EPS This Year
0.66
from -0.52
EPS Next Year
0.86
from 0.66
Increased by 29.44%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 593.3M | 632.9M | 656.3M |
| Avg | 570.5M | 605.3M | 631.3M |
| Low | 553.4M | 583.1M | 612.5M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 3.5% | 10.9% | 8.4% |
| Avg | -0.5% | 6.1% | 4.3% |
| Low | -3.5% | 2.2% | 1.2% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 0.69 | 1.04 | 0.82 |
| Avg | 0.66 | 0.86 | 0.79 |
| Low | 0.64 | 0.70 | 0.76 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | - | 56.7% | -4.6% |
| Avg | - | 29.4% | -8.2% |
| Low | - | 4.9% | -11.0% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.